Search Results - "Abutarif, Malaz A"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Evaluation of the exposure equivalence of oral versus intravenous temozolomide by Diez, Blanca D, Statkevich, Paul, Zhu, Yali, Abutarif, Malaz A, Xuan, Fengjuan, Kantesaria, Bhavna, Cutler, David, Cantillon, Marc, Schwarz, Max, Pallotta, Maria Guadalupe, Ottaviano, Fabio H

    Published in Cancer chemotherapy and pharmacology (01-03-2010)
    “…Purpose Oral temozolomide is approved in many countries for malignant glioma and for melanoma in some countries outside the USA. This study evaluated the…”
    Get full text
    Journal Article
  2. 2

    Exposure-Response of Quizartinib Efficacy in Patients with Relapsed/Refractory AML by Kang, Dongwoo, Passarell, Julie, Abutarif, Malaz A, Mendell, Jeanne, Yin, Ophelia

    Published in Blood (13-11-2019)
    “…Introduction: Quizartinib is a once-daily, oral, highly potent and selective FLT3 inhibitor that has shown clinical activity in patients with…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Population Pharmacokinetics (PK) of Oral Posaconazole (POS) for Antifungal Prophylaxis in Neutropenic Patients with Hematologic Malignancies by AbuTarif, Malaz A., Krishna, Gopal, Statkevich, Paul

    Published in Blood (16-11-2007)
    “…In a recent large, randomized, multicenter study in neutropenic patients undergoing remission-induction chemotherapy for acute myelogenous leukemia or…”
    Get full text
    Journal Article